VELCADE,Rituximab,Cyclophosphamide and Decadron

NCT00413959 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Lymphoma, Non-Hodgkin
Lymphoma, B-Cell

Interventions

DRUG: VELCADE®
DRUG: Rituximab
DRUG: Cyclophosphamide
DRUG: Decadron

Sponsor

Oncology Specialists, S.C.

Collaborators

[object Object]